Skip to main content

Healthy Adult

10
Pipeline Programs
9
Companies
15
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
10
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Jeil Pharmaceutical
Jeil PharmaceuticalKorea - Seoul
3 programs
3
JLP-1901Phase 11 trial
JLP-2004Phase 11 trial
SGLT2 inhibitorPhase 11 trial
Active Trials
NCT06171880Completed48Est. May 2022
NCT06169059Completed60Est. Nov 2023
NCT06165965Completed48Est. Jun 2022
Dong-A ST
Dong-A STKorea - Seoul
2 programs
2
DA-5223Phase 12 trials
DA-5223-RPhase 11 trial
Active Trials
NCT07633691Recruiting12Est. Jun 2026
NCT07007520Withdrawn0Est. Nov 2025
NCT07007533Completed38Est. Jul 2025
Daewon Pharma
Daewon PharmaKorea - Hwaseong
2 programs
2
DW4421Phase 11 trial
DW5524Phase 11 trial
Active Trials
NCT07343245Recruiting150Est. Jun 2026
NCT07349589Not Yet Recruiting48Est. Dec 2026
BioTherapeutics Inc
BioTherapeutics IncVA - Blacksburg
1 program
1
SON-1010Phase 1
Sonnet BioTherapeutics
1 program
1
SON-1010Phase 11 trial
Active Trials
NCT05408572Completed32Est. May 2023
Voronoi
VoronoiKorea - Incheon
1 program
1
VRN101099Phase 11 trial
Active Trials
NCT07550946Not Yet Recruiting24Est. Sep 2026
Eisai
EisaiChina - Liaoning
2 programs
Donepezil HydrochloridePHASE_11 trial
Donepezil HydrochloridePHASE_11 trial
Active Trials
NCT01506752Completed20Est. Sep 2011
NCT01506739Completed12Est. May 2011
Bristol Myers Squibb
1 program
BMS-986142PHASE_13 trials
Active Trials
NCT02880670Completed9Est. Sep 2016
NCT02832180Completed25Est. Oct 2016
NCT02257151Completed118Est. Aug 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Dong-A STDA-5223
VoronoiVRN101099
Daewon PharmaDW5524
Daewon PharmaDW4421
Dong-A STDA-5223
Dong-A STDA-5223-R
Jeil PharmaceuticalJLP-2004
Sonnet BioTherapeuticsSON-1010
Jeil PharmaceuticalSGLT2 inhibitor
Jeil PharmaceuticalJLP-1901
Bristol Myers SquibbBMS-986142
Bristol Myers SquibbBMS-986142
Bristol Myers SquibbBMS-986142
EisaiDonepezil Hydrochloride
EisaiDonepezil Hydrochloride

Clinical Trials (15)

Total enrollment: 644 patients across 15 trials

A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects

Start: Jun 2026Est. completion: Jun 202612 patients
Phase 1Recruiting

Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN101099 in Healthy Adult Participants

Start: May 2026Est. completion: Sep 202624 patients
Phase 1Not Yet Recruiting

Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers

Start: Feb 2026Est. completion: Dec 202648 patients
Phase 1Not Yet Recruiting

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

Start: Dec 2025Est. completion: Jun 2026150 patients
Phase 1Recruiting

A Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects

Start: Nov 2025Est. completion: Nov 20250
Phase 1Withdrawn

A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects

Start: Jul 2025Est. completion: Jul 202538 patients
Phase 1Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004

Start: Oct 2023Est. completion: Nov 202360 patients
Phase 1Completed

Study of SON-1010 (IL12-FHAB) in Healthy Adults

Start: Jul 2022Est. completion: May 202332 patients
Phase 1Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008

Start: May 2022Est. completion: Jun 202248 patients
Phase 1Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901

Start: Feb 2022Est. completion: May 202248 patients
Phase 1Completed

Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects

Start: Aug 2016Est. completion: Sep 20169 patients
Phase 1Completed

The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects

Start: May 2016Est. completion: Oct 201625 patients
Phase 1Completed

Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects

Start: Sep 2014Est. completion: Aug 2015118 patients
Phase 1Completed
NCT01506752EisaiDonepezil Hydrochloride

A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males

Start: Jul 2011Est. completion: Sep 201120 patients
Phase 1Completed
NCT01506739EisaiDonepezil Hydrochloride

A Bioequivalence Study of Film-coated Tablet and Dry Syrup 1% Form for E2020 in Healthy Japanese Adult Males

Start: Mar 2011Est. completion: May 201112 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 644 patients
9 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.